These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17404366)

  • 1. Adjuvant chemotherapy for high-risk operable breast cancer.
    Buzdar AU
    J Clin Oncol; 2007 May; 25(13):1642-4. PubMed ID: 17404366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Have therapeutic measures improved the prognosis of operable breast cancer? Adjuvant chemotherapy].
    Senn HJ
    Verh Dtsch Ges Inn Med; 1985; 91():421-8. PubMed ID: 4090642
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction chemotherapy of breast cancer.
    Hortobagyi GN; Buzdar AU; Ames FC; Blumenschein GR; Montague ED
    Prog Clin Biol Res; 1985; 201():105-16. PubMed ID: 4095105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Future direction of adjuvant chemotherapy for breast cancer following new risk categories of St. Gallen Consensus].
    Osaki A; Saeki T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():407-13. PubMed ID: 17682185
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative chemotherapy in the treatment of inflammatory breast cancer.
    Keiling R; Guiochet N; Calderoli H; Hurteloup P; Krzisch C
    Prog Clin Biol Res; 1985; 201():95-104. PubMed ID: 4095121
    [No Abstract]   [Full Text] [Related]  

  • 6. [New approaches in adjuvant chemotherapy of breast cancer].
    Salzer H; Sevelda P
    Gynakol Rundsch; 1988; 28(2):123-5. PubMed ID: 3402824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neoadjuvant systemic chemotherapy for patients with operable breast cancer].
    Zhang B; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):161-5. PubMed ID: 17649628
    [No Abstract]   [Full Text] [Related]  

  • 8. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
    Tamura K
    Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.
    Moore HC; Green SJ; Gralow JR; Bearman SI; Lew D; Barlow WE; Hudis C; Wolff AC; Ingle JN; Chew HK; Elias AD; Livingston RB; Martino S;
    J Clin Oncol; 2007 May; 25(13):1677-82. PubMed ID: 17404368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term tamoxifen therapy for breast cancer.
    Jordan VC
    Important Adv Oncol; 1989; ():179-92. PubMed ID: 2651287
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant therapy for breast cancer: we are solving the puzzle, but pieces are still missing.
    Pritchard KI
    J Natl Cancer Inst; 2007 Apr; 99(7):494-5. PubMed ID: 17405988
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of adjuvant chemotherapy for breast cancer.
    Bonadonna G; Valagussa P
    Semin Oncol; 1987 Mar; 14(1):8-22. PubMed ID: 3547668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Post-surgical adjuvant treatment of breast cancer].
    Román JM; Martín M
    Rev Clin Esp; 1990 Jan; 186(1):1-4. PubMed ID: 2181563
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
    Bonadonna G; Valagussa P; Veronesi U
    J Clin Oncol; 2008 Jan; 26(3):342-4. PubMed ID: 18202404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intensive chemotherapy in day hospitals].
    Farnault G
    Soins Gynecol Obstet Pueric Pediatr; 1985 Mar; (46):45-8. PubMed ID: 3847184
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.
    Kuo SH; Lien HC; You SL; Lu YS; Lin CH; Chen TZ; Huang CS
    Breast; 2008 Dec; 17(6):646-53. PubMed ID: 18595699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab: new indication. Metastatic breast cancer: many adverse effects.
    Prescrire Int; 2008 Dec; 17(98):236. PubMed ID: 19422148
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New agents and new medical treatments for advanced breast cancer.
    Henderson IC; Hayes DF; Come S; Harris JR; Canellos G
    Semin Oncol; 1987 Mar; 14(1):34-64. PubMed ID: 3547667
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant therapy for breast cancer.
    Elias EG
    Md Med J; 1986 Sep; 35(9):737. PubMed ID: 3762340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.